In Depth

How sham patents are hurting the pharma industry

Tracking the opioid lawsuit settlements amidst calls for oversight

Cell and gene therapy landscape in the US

Q&A: Cell and gene therapy value assessments need a rework to allow access

Q&A: Pharmaceutical discovery through a gravitational lens